Major Depression in Medically 111 Patients

Mayo Clinic Proceedings

Volumn 73, Issue 4, 1998, Pages 329-337

  Sutor, Bruce ^a   Rummans, Teresa A ^b   Jowsey, Sheila G ^a   Krahn, Lois E ^b   Martin, Maurice J ^a   Kevin O'Connor, M ^a   Philbrick, Kemuel L ^a   Richardson, Jarrett W ^b  

^a MAYO CLINIC ROCHESTER   (United States)

^b U of MN St Cloud Hospital FMR   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DEPRESSION; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; HUMAN; ILLNESS BEHAVIOR; PREVALENCE; PROGNOSIS; PSYCHIATRIC DIAGNOSIS; TREATMENT PLANNING;

EID: 0031917973     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/73.4.329     Document Type: Article

References (66)

1. Burvill PW. Recent progress in the epidemiology of major depression. Epidemiol Rev 1995;17:21-31
2. Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994;151:979-986
3. Hendrie HC, Callahan CM, Levitt EE, Hui SL, Musick B, Austrom MG, et al. Prevalence rates of major depressive disorders: the effects of varying the diagnostic criteria in an older primary care population. Am J Geriatr Psychiatry 1995:3:119-131
4. Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988:145:976-981
5. Burvill PW, Johnson GA, Jamrozik KD, Anderson CS, Stewart-Wynne EG, Chakera TM. Prevalence of depression after stroke: the Perth Community Stroke Study. Br J Psychiatry 1995:166:320-327
6. Robinson RG, Starr LB, Price TR. A two year longitudinal study of mood disorders following stroke: prevalence and duration at six months follow-up. Br J Psychiatry 1984:144:256-262
7. Sano M, Stern Y, Williams J, Cote L, Rosenstein R, Mayeux R. Coexisting dementia and depression in Parkinson's disease. Arch Neurol 1989:46:1284-1286
8. Greenwald BS, Kramer-Ginsberg E, Marin DB, Laitman LB, Hermann CK, Mohs RC, et al. Dementia with coexistent major depression. Am J Psychiatry 1989:146:1472-1478
9. Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlln R, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989:149:1785-1789
10. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival [published erratum appears in JAMA 1994;271:1082]. JAMA 1993;270:1819-1825
11. Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary heart disease: a 12-month follow-up. Gen Hosp Psychiatry 1996:18:61-65
12. Carney RM, Rich MW, Tevelde A, Saini J, Clark K, Jaffe AS. Major depressive disorder in coronary artery disease. Am J Cardiol 1987; 60:1273-1275
13. Burkberg J, Penman D, Holland JC. Depression in hospitalized cancer patients. Psychosom Med 1984;46:199-212
14. Kathol RG, Mutgi A, Williams J, Clamon G, Noyés R Jr. Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiatry 1990;147:1021-1024
15. Joffe RT, Rubinow DR, Denicoff KD, Mäher M, Sindelar WF. Depression and carcinoma of the pancreas. Gen Hosp Psychiatry 1986:8:241-245
16. Goodnick PJ, Henry JH, Buki VM. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 1995:56:128-136
17. Brown GR, Rundell JR, McManis SE, Kendall SN, Zachary R, Temoshok L. Prevalence of psychiatric disorders in early stages of HIV infection. Psychosom Med 1992;54:588-601
18. Downhill JE Jr, Robinson RG. Longitudinal assessment of depression and cognitive impairment following stroke. J Nerv Ment Dis 1994:182:425-431
19. Morris PL, Robinson RG, Raphael B. Emotional lability after stroke. Aust NZJ Psychiatry 1993:27:601-605
20. Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996;53:175-182
21. Fann JR, Katon WJ, Vomoto JM, Esselman PC. Psychiatric disorders and functional disability in outpatients with traumatic brain injuries. Am J Psychiatry 1995:152:1493-1499
22. Schubert DS, Foliart RH. Increased depression in multiple sclerosis patients: a meta-analysis. Psychosomatics 1993:34:124-130
23. Roose SP, Dalack GW, Woodring S. Death, depression, and heart disease. J Clin Psychiatry 1991;52(Suppl):34-39
24. Kennedy GJ, Hofer MA, Cohen D, Shindledecker R, Fisher JD. Significance of depression and cognitive impairment in patients undergoing programed stimulation of cardiac arrhythmias. Psychosom Med 1987:49:410-421
25. Aromaa A, Raitasalo R, Reunanen A, Impivaara 0, Heliovaara M, Knekt P, et al. Depression and cardiovascular diseases. Acta Psychiatr Scand Suppl 1994:377:77-82
26. Lansky SB, List MA, Herrmann CA, Ets-Hokin EG, DasGupta TK, Wilbanks GD, et al. Absence of major depressive disorder in female cancer patients. J Clin Oncol 1985:3:1553-1560
27. Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983:249:751-757
28. Lynch ME. The assessment and prevalence of affective disorders in advanced cancer. J Palliât Care 1995:11:10-18
29. Valente SM, Saunders JM, Cohen MZ. Evaluating depression among patients with cancer. Cancer Pract 1994;2:65-71
30. Wells KB, Golding JM, Burnam MA. Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. Gen Hosp Psychiatry 1989:11:320-327
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington (DC): American Psychiatric Association: 1994
32. Endicott J. Measurement of depression in patients with cancer. Cancer 1984:53:2243-2249
33. von Ammon Cavanaugh S. Depression in the medically ill: critical issues in diagnostic assessment. Psychosomatics 1995:36:4859
34. Gabbard GO. Psychodynamic Psychiatry in Clinical Practice. Washington (DC): American Psychiatric Press; 1990
35. Spiegel D. Cancer and depression. Br J Psychiatry Suppl 1996:30:109-116
36. Greer S, Moorey S, Baruch JD, Watson M, Robertson BM, Mason A, et al. Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. BMJ 1992:304:675-680
37. Spiegel D, Bloom JR, Yalom I. Group support for patients with metastatic cancer: a randomized outcome study. Arch Gen Psychiatry 1981:38:527-533
38. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989:2:888-891
39. Cunningham LA. Depression in the medically ill: choosing an antidepressant. J Clin Psychiatry 1994;55(Suppl A):90-97
40. Roose SP, Glassman AH. Antidepressant choice in the patient with cardiac disease: lessons from the Cardiac Arrhythmia Suppression Trial (CAST) studies. J Clin Psychiatry 1994;55(Suppl A):83-87
41. Strain JJ, Caliendo G, Himelein C, Hammer JS. Part II. Drugpsychotropic drug interactions and end organ dysfunction: clinical management recommendations, selected bibliography, and updating strategies. Gen Hosp Psychiatry 1996:18:300-313
42. Rifkin A, Reardon G, Siris S, Karagji B, Kim YS, Hackstaff L, et al. Trimipramine in physical illness with depression. J Clin Psychiatry 1985;46(No. 2. Sec. 2):4-8
43. Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 1992;33:190-201
44. Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984:1:297-300
45. Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E, et al. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry 1989;146:45-49
46. Gregory RJ, Jimerson DC, Walton BE, Daley J, Paulsen RH. Pharmacotherapy of depression in the medically ill: directions for future research. Gen Hosp Psychiatry 1992;14:36-42
47. Stoudemire A. Expanding psychopharmacologic treatment options for the depressed medical patient. Psychosomatics 1995;36(Suppl 1):S19-S26
48. Richelson E. Pharmacology of antidepressants-characteristics of the ideal drug. Mayo Clin Proc 1994;69:1069-1081
49. Janicak PG, Davis JM, Preskorn SH, Ayd FJ Jr. Principles ana Practice of Psychopharmacotherapy. Baltimore: Williams & Wilkins; 1993
50. Spier SA, Frontera MA. Unexpected deaths in depressed medical inpatients treated with fluoxetine. J Clin Psychiatry 1991;52:377-382
51. Ereshefsky L, Riesenman C, Lam YW. Antidepressant drug interactions and the cytochrome P450 system: the role of cytochrome P450 2D6. Clin Pharmacokinet 1995;29(Suppl 1):10-18
52. Miller FT, Freilicher J. Comparison of TCAs and SSRIs in the treatment of major depression in hospitalized geriatric patients. J Geriatr Psychiatry Neurol 1995:8:173-176
53. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994:25:1099-1104
54. Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996:27:1211-1214
55. Koriech OM. Fluoxetine treatment comprises the antiemetic efficacy of ondansetron in cancer patients. Clin Oncol (R Coll Radiol) 1995:7:371-372
56. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992:149:443-454
57. Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EG. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 1991;148:512-516
58. Preskorn SH. Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiatry 1993;54(Suppl):1434
59. Lief HI. Bupropion treatment of depression to assist smoking cessation [letter]. Am J Psychiatry 1996:153:442
60. Feighner JP. Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry 1995;56:574-579
61. Stoudemire A, Moran MG, Fogel BS. Psychotropic drug use in the medically ill. Parti. Psychosomatics 1990:31:377-391
62. Wallace AE, Kofoed LL, West AN. Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. Am J Psychiatry 1995:152:929-931
63. Masand PS, Tesar GE. Use of stimulants in the medically ill. Psychiatr Clin North Am 1996 Sep;19:515-547
64. Philbrick KL, Rummans TA. Malignant catatonia. J Neuropsychiatry Clin Neurosci 1994;6:1-13
65. Weiner RD, Coffey CE. Electroconvulsive therapy in the medical and neurologic patient. In: Stoudemire A, Fogel BS, editors. Psychiatric Care of the Medical Patient. New York: Oxford University Press; 1993. pp 207-224
66. Rummans TA. Medical indications for electroconvulsive therapy. Psychiatr Ann 1993:23:27-32